FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation ( https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its ...
Planegg/Martinsried, October 16, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR) ...
Lieberman is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center ... In most healthy individuals, EBV reactivation is asymptomatic because other ...
This summer’s IPO by Artiva Biotherapeutics Inc. highlighted early stage efforts with natural killer cells in autoimmune disease, where a handful of companies are advancing programs. The firm raised ...
GMP Cell Therapy Consumables market is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031.
Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell ...
State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, ...